Form 4: Oncology Institute Director Brad Hively Sells Shares to Cover Tax Obligations
SEC Form 4
Director Brad Hively of Oncology Institute, Inc. [TOI] sold 19,526 shares of common stock on May 22, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On May 22, 2024, Brad Hively, a director at Oncology Institute, Inc. [TOI], sold 19,526 shares of common stock.
- The sale was executed at a price of $0.5753 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- Following the transaction, Hively directly owns 694,324 shares of Oncology Institute, Inc.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover tax obligations). It doesn't indicate positive or negative sentiment.
Industry Context
Sales to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and directors.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 05/22/2024 | Date of transaction: Brad Hively sold shares of Oncology Institute, Inc. |
| 05/23/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.